$20m cash in the upcoming quarterly would be a great result.
It's thoroughly believable that deals are contingent on an FDA go ahead, if any deal happens the validation will send the SP soaring imo.
Sharewise Presentation 22/7/24, page-43
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.8¢ | 23.0¢ | $155.1K | 661.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 365364 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 11500 | 3 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |